Response of the Netherlands to the public consultation of the Roadmap of the European Commission on the Pharmaceutical Strategy

The Netherlands takes the opportunity to respond to the open consultation of the European Commission on the Pharmaceutical Strategy.

Access to affordable medicines and a healthy, competitive EU market are crucial for the health of the European people and for the security and autonomy of the European Union.